Health Informa.cs. Lecture 7. Samantha Kleinberg
|
|
- Penelope Davidson
- 5 years ago
- Views:
Transcription
1 Health Informa.cs Lecture 7 Samantha Kleinberg samantha.kleinberg@stevens.edu
2 Prac.cali.es: preserving privacy
3 Good prac.ces for preserving privacy Physical security Locked cabinet/office, don t print records and leave them in common area/on desk Encryp.on Losing laptop/thumbdrive, sending harddrive for repair can be disastrous Restricted access to servers with PHI PHI in segregated, labeled, directories
4 Limits of deiden.fica.on "87% of the U.S. Popula.on are uniquely iden.fied by {date of birth, gender, ZIP}." hpp://latanyasweeney.org/work/ iden.fiability.html
5
6
7
8 Back to data challenges Observa.onal Data in general Nonsta.onarity Selec.on bias Choosing variables Seeing vs doing Biomedical Data Biased approxima.on of truth Sample size Censoring (le^, right) Ins.tu.onal differences Fragmenta.on of data
9 Treatment Dead Alive A (72%) B (80%) Total
10 Simpson s paradox Treatment Men Women Combined Dead Alive Dead Alive Dead Alive A (60%) 5 95 (95%) (72%) B (50%) (85%) (80%) Total Baker SG, Kramer BS (2001) Good for women, good for men, bad for people: Simpson's paradox and the importance of sex-specific analysis in observa.onal studies. Journal of women's health & gender-based medicine 10:
11 Bias in graduate admissions? Admit Deny Male Female P(admiPed)= 5232/ P(admiPed female) =1494/ P(admiPed male)=3738/ Bickel, P. J., Hammel, E. A., & O'connell, J. W. (1975). Sex bias in graduate admissions: Data from berkeley. Science, 187(4175), 398
12 Simpson s paradox Men Women Dept Applied % AdmiPed Applied AdmiPed A B C D E F hpp://vudlab.com/simpsons/
13 Alice s pa.ent outcomes Bob s pa.ent outcomes
14 Selec.on bias Alice s pa.ent popula.on Bob s pa.ent popula.on
15 A+H à Hospital Find associa.on between A, H because not seeing A and H separately in hospital popula.on
16 Selec.on bias Drug given to sicker pa.ents -> worse outcomes? Running/mortality Hospital outcomes depend on popula.on: socioeconomic factors, medical insurance, etc.
17 Variable selec.on/granularity Problem specific What level in ICD9 hierarchy to use? Redundancy? Hidden common causes
18 Nurses Health study followed ~122,000 nurses every 2 years since the 1970 s Analysis in the 90 s showed women taking HRT a^er menopause have decreased risk of heart apacks (37% lower death rate, 53% lower risk of CV death) HERS trial: RCT showing no effect WHI: RCT where heart apacks increase 29% (from 30 to 37 per 10,000 person-years) Latest: HRT may be beneficial if it s started early
19 Doing vs seeing: randomiza.on (more next week) Sever link between causes of interven.on and effects (selec.on bias) E.g. birth control pills and pregnancy Isolate cause Single difference between groups, removes confounding Blinding Confirma.on bias
20 Missing data/error Device malfunc.on E.g. thermometer moves and now measure room temp Network problem Data recorded but not stored Data exists somewhere Human error misrecorded data/omiped data Pa.ent factors omizng data/giving false info
21 Timing variability Note describes chronology a^er the fact Labs not exact When do people go to dr? (hint: a^er symptoms start) Interven.ons recorded a^er they re done
22 Sample size Big data doesn t guarantee sufficient power! Would you rather have 10 pa.ents monitored in great detail or a few datapoints on 10K pa.ents?
23 Censoring Le^: what happened before admission to hospital? Right: what s outcome a^er leaving hospital?
24 Fragmenta.on Do you go to the same doctors at home and when classes are in session? How are records shared?
25 Controls Usually matched to cases, but technical difficul.es Is selec.on criteria structured or unstructured? Is same data available on both? If comparing against healthy people, will there be enough data? What happens if some cases are actually controls?
26
27 Manual review Automated review
28 Mul.ple Tes.ng BenneP, C. M., Miller, M. B., & Wolford, G. L. (2009). Neural correlates of interspecies perspec.ve taking in the post-mortem atlan.c salmon: An argument for mul.ple comparisons correc.on. NeuroImage, 47(1), 125.
29 Mul.ple comparisons hpp://xkcd.com/882/
30
31 This analysis revealed that only in ~20-25% of the projects were the relevant published data completely in line with our in-house findings
32 Fi^y-three papers were deemed landmark studies scien.fic findings were confirmed in only 6 (11%) cases.
33
34 Goals Uncover bias Find confounders Detect limits, generalizability Validate methods/findings
35 Pa.ents heterogeneous Popula.ons have different characteris.cs Sample size Not all data available everywhere (+ retrospec.ve) Data quality (noisy, sparse, missing) Replica.on doesn t validate methods Need ground truth Need controlled data
36 Today s paper
Causal Inference from Complex Observa4onal Data. Samantha Kleinberg
Causal Inference from Complex Observa4onal Data Samantha Kleinberg samantha.kleinberg@stevens.edu Three key points We need causal knowledge Causes are hard to find It s not hopeless! Most striking, society
More informationHealth Informa.cs. Lecture 9. Samantha Kleinberg
Health Informa.cs Lecture 9 Samantha Kleinberg samantha.kleinberg@stevens.edu Next week: journal club For all papers: read, and prepare to comment on For your paper: Read the ar.cle (+ other references
More informationLearning Objec1ves. Study Design Considera1ons in Clinical Pharmacy
9/28/15 Study Design Considera1ons in Clinical Pharmacy Ludmila Bakhireva, MD, PhD, MPH Pree Sarangarm, PharmD, BCPS Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal
More informationLearning Objec1ves. Study Design Strategies. Cohort Studies 9/28/15
9/28/15 Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal study designs Explain why the overall study design is important when evalua1ng studies & applying their
More informationCausal Inference from Complex Observational Data. Samantha Kleinberg Stevens Institute of Technology
Causal Inference from Complex Observational Data Samantha Kleinberg Stevens Institute of Technology samantha.kleinberg@stevens.edu Three key points We need causal knowledge Causes are hard to find and
More informationJournée d étude du Cogmaster Good (and less good) lab prac8ces
Journée d étude du Cogmaster Good (and less good) lab prac8ces Saturday 25 octobre 2014 9h30 10h30: overview of lab prac8ces 11h30 15h30 Lab Notebook 11h35 11h55: summarizing/clarifying the notebook 11h55
More informationPragma&c Clinical Trials
Pragma&c Clinical Trials Susanne May, PhD Associate Professor Department of Biosta&s&cs, School of Public Health, University of Washington Preliminaries PLEASE ask ques&ons at any &me REALLY good clinical
More informationPost-Opera5ve Use of the Wheeled Knee Walker a<er Foot and Ankle Surgery
Post-Opera5ve Use of the Wheeled Knee Walker a
More information3/31/2015. Designing Clinical Research Studies: So You Want to Be an
Designing Clinical Research Studies: So You Want to Be an Inves@gator Andrea Bonny, MD Ellen Lançon Connor, MD On behalf Of The NASPAG Research CommiPee Objec@ves Learn to design a clinical research project
More informationSimpson s Paradox and the implications for medical trials
Simpson s Paradox and the implications for medical trials Norman Fenton, Martin Neil and Anthony Constantinou 31 August 2015 Abstract This paper describes Simpson s paradox, and explains its serious implications
More informationConfounding Bias: Stratification
OUTLINE: Confounding- cont. Generalizability Reproducibility Effect modification Confounding Bias: Stratification Example 1: Association between place of residence & Chronic bronchitis Residence Chronic
More informationWelcome! Pragmatic Clinical Studies. David Hickam, MD, MPH Program Director Clinical Effectiveness Research. David Hickam, MD, MPH
Pragmatic Clinical Studies David Hickam, MD, MPH Program Director Clinical Effec2veness Research June 23, 2015 Welcome! David Hickam, MD, MPH Program Director Clinical Effectiveness Research 2 In this
More informationEconomic outcomes: Method for implementa5on
Economic outcomes: Method for implementa5on Philippe Beutels Centre for Health Economics Research & Modelling Infec
More informationCausal Inference: predic1on, explana1on, and interven1on
Causal Inference: predic1on, explana1on, and interven1on Lecture : Mechanisms, Interven1ons, and Randomized Controlled Trials Samantha Kleinberg samantha.kleinberg@stevens.edu Blame Who s at fault for
More informationSta$s$cs is Easy. Dennis Shasha From a book co- wri7en with Manda Wilson
Sta$s$cs is Easy Dennis Shasha From a book co- wri7en with Manda Wilson Is the Coin Fair? You toss a coin 17 $mes and it comes up heads 15 out of 17 $mes. How likely is it that coin is fair? Could look
More informationMalnutri)on Universal Screening Tool (MUST)
Malnutri)on Universal Screening Tool () Nutri&on screening mandated in acute care se1ngs in the US, UK and Canada - Iden&fy malnourished pa&ents and those at risk à warrant more detailed assessment/treatment
More informationUnderstanding. Design & Sta/s/cs. in Clinical Trials
Understanding Design & Sta/s/cs in Clinical Trials 1 Why bother? 2 Experience- Based Medicine? Benjamin Rush Father of American Psychiatry 3 Experience- Based Medicine? Supported blood- lejng as treatment
More informationPHILOSOPHY OF ECONOMICS & POLITICS
PHILOSOPHY OF ECONOMICS & POLITICS LECTURE 12: EVIDENCE-BASED SOCIAL POLICY DATE 21 JANUARY 2019 LECTURER JULIAN REISS Today s agenda Recall Michael Young: segregation works obviously! But how do we know?
More informationConflicts of interest. Objec5ves / Outline. Pulmonary rehabilita5on. Pulmonary rehabilita5on in COPD. Pulmonary rehabilita5on in COPD 11/26/13
Conflicts of interest UBC I have no conflicts of interest related to this presenta5on Treatment op+ons From a global perspec+ve: Non- pharmaceu+cal treatments Pulmonary Fibrosis Founda5on Summit La Jolla,
More informationAggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results
Aggressive Medical Management with or without Angioplasty and Sten8ng for Symptoma8c Intracranial Atherosclero8c Stenosis: Long Term Results Disclosures Funding by NINDS U01 NS058728 Boston Scien8fic provided
More informationA review of approaches to identifying patient phenotype cohorts using electronic health records
A review of approaches to identifying patient phenotype cohorts using electronic health records Shivade, Raghavan, Fosler-Lussier, Embi, Elhadad, Johnson, Lai Chaitanya Shivade JAMIA Journal Club March
More informationUniversal Design and Evalua2on. 4. Ethical Considera2ons
Universal Design and Evalua2on 4. Ethical Considera2ons What is Ethics? Moral Philosophy (not necessarily connected to legal aspects) Human behaviour No fixed rules What is happening here? Why Ethics?
More informationMAKING PRAGMATIC TRIALS WORK
MAKING PRAGMATIC TRIALS WORK iden6fica6on of opera6onal challenges & development of a decision support tool for pragma6c trial design WP3 Iris Goetz, Mira Zuidgeest November 24, 2016 Pragma6c trials on
More informationCommon Data Elements: Making the Mass of NIH Measures More Useful
Common Data Elements WG Common Data Elements: Making the Mass of NIH Measures More Useful Jerry Sheehan Assistant Director for Policy Development Na?onal Library of Medicine Gene/c Alliance Webinar Series
More informationDesign, Conduct and Analysis of Pragma?c Clinical Trials in Pallia?ve Care Research
Design, Conduct and Analysis of Pragma?c Clinical Trials in Pallia?ve Care Research Sco$ D. Halpern, M.D., Ph.D. Associate Professor of Medicine, Epidemiology, and Medical Ethics & Health Policy Director,
More informationTruth Versus Truthiness in Clinical Data
Temple University Health System Truth Versus Truthiness in Clinical Data Mark Weiner, MD, FACP, FACMI Assistant Dean for Informatics, Temple University School of Medicine mark.weiner@tuhs.temple.edu 1
More informationCasual Methods in the Service of Good Epidemiological Practice: A Roadmap
University of California, Berkeley From the SelectedWorks of Maya Petersen 2013 Casual Methods in the Service of Good Epidemiological Practice: A Roadmap Maya Petersen, University of California, Berkeley
More informationWelcome to Pa+ent Safety in Epilepsy Monitoring Units. Cosponsored by the American Epilepsy Society and the Na7onal Associa7on of Epilepsy Centers
Welcome to Pa+ent Safety in Epilepsy Monitoring Units Cosponsored by the American Epilepsy Society and the Na7onal Associa7on of Epilepsy Centers Overview of Educa+onal Program Web- based program designed
More informationMain objective of Epidemiology. Statistical Inference. Statistical Inference: Example. Statistical Inference: Example
Main objective of Epidemiology Inference to a population Example: Treatment of hypertension: Research question (hypothesis): Is treatment A better than treatment B for patients with hypertension? Study
More informationLeveraging the HSX Clinical Data Repository to Improve Behavioral Health Care:
Leveraging the HSX Clinical Data Repository to Improve Behavioral Health Care: Insights from the Montgomery County Hospital Partnership HEALTHSHARE EXCHANGE BOARD OF TRUSTEES ANNUAL MEETING NOVEMBER 14,
More informationA Transla)onal Framework for Methodological Rigor to Improve Pa)ent Centered Outcomes in End of Life Cancer Research
A Transla)onal Framework for Methodological Rigor to Improve Pa)ent Centered Outcomes in End of Life Cancer Research Francesca Dominici, PhD Senior Associate Dean for Research Professor of Biostatistics
More informationTHE RARE DISEASES CLINICAL RESEARCH NETWORK AS A NESTED CULTURAL COMMONS
THE RARE DISEASES CLINICAL RESEARCH NETWORK AS A NESTED CULTURAL COMMONS Bre5 Frischmann, Benjamin N. Cardozo School of Law Katherine J. Strandburg, NYU School of Law Can Cui, NYU School of Law Case study
More informationCausal Inference. Sandi McCoy, MPH, PhD University of California, Berkeley July 16, 2011
Causal Inference Sandi McCoy, MPH, PhD University of California, Berkeley July 16, 2011 Enhancing Implementa/on Science: Program Planning, Scale- up, and Evalua/on Program? Outcome Fidelity Other programs
More information6 Disasters in FCC Numbering: How it can be a disaster or a huge benefit? Dr. Z August, 2009
6 Disasters in FCC Numbering: How it can be a disaster or a huge benefit? Dr. Z August, 2009 Real Numbers The number you have been using on your Sorenson VP may be a fake number. The FCC order forces Sorenson
More informationBreast Cancer How to reduce your risk
Prevention Series Breast Cancer How to reduce your risk Let's Make Cancer History 1 888 939-3333 www.cancer.ca Breast Cancer How to reduce your risk Breast cancer develops in abnormal cells in the breast
More informationConfounding and Effect Modification. John McGready Johns Hopkins University
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationParien' JJ, Mongardon N, Megarbane B et al. Intravascular Complica'ons of Central Venous Catheteriza'on by Inser'on Site. New England Journal of
Parien' JJ, Mongardon N, Megarbane B et al. Intravascular Complica'ons of Central Venous Catheteriza'on by Inser'on Site. New England Journal of Medicine 2015; 373: 1220-9 The Study 3SITES Study Mul'na'onal,
More informationStudy Methodology: Tricks and Traps
Study Methodology: Tricks and Traps Designed Experiments Observational Studies Weighted Averages 1 1. DEs and OSs Chapters 1 and 2 contrast designed experiments (DEs) with observational studies (OSs).
More informationMedical informa.on, flow and building rapid learning cancer knowledge centers
Medical informa.on, flow and building rapid learning cancer knowledge centers Craig Nichols, MD Visi.ng Professor Bri.sh Columbia Cancer Agency Director- Tes.cular Cancer Consor.um LIVESTRONG- Health Informa.on
More informationPYSC 224 Introduction to Experimental Psychology
PYSC 224 Introduction to Experimental Psychology Session 8 Controlling Extraneous Variables Lecturer: Dr. Margaret Amankwah-Poku, Dept. of Psychology Contact Information: mamankwah-poku@ug.edu.gh College
More informationEngage and Empower Pa.ents with Interac.ve Technology. Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012
Engage and Empower Pa.ents with Interac.ve Technology Northeast NAHAM Regional Conference Pa.ent Access: GeBng It Right Upfront October 22-23, 2012 NAHAM - Pa.ent Access Services 2 Pa%ent Access Services
More informationWhat Happened in the IN.PACT Deep Trial. Zaheed Tai, DO,FACC,FSCAI Bos4ck Heart Center Winter Haven, FL
What Happened in the IN.PACT Deep Trial Zaheed Tai, DO,FACC,FSCAI Bos4ck Heart Center Winter Haven, FL BTK Revasculariza>on Challenges Long, complex, ocen calcified nature of lesions 1 OCen associated
More informationPrac%cing and Thriving in an Unlicensed State
Prac%cing and Thriving in an Unlicensed State WHY? What can you do? How do you prac%ce? Don t you want to be in a licensed state? Naturo- what?? FEAR...the discouraging factor Legal Ramifica%ons Disregard
More informationLecture 9 Internal Validity
Lecture 9 Internal Validity Objectives Internal Validity Threats to Internal Validity Causality Bayesian Networks Internal validity The extent to which the hypothesized relationship between 2 or more variables
More informationThe Healthy User Effect: Ubiquitous and Uncontrollable S. R. Majumdar, MD MPH FRCPC FACP
The Healthy User Effect: Ubiquitous and Uncontrollable S. R. Majumdar, MD MPH FRCPC FACP Professor of Medicine, Endowed Chair in Patient Health Management, Health Scholar of the Alberta Heritage Foundation,
More informationEvidence Informed Practice Online Learning Module Glossary
Term Abstract Associations Attrition Bias Background and Significance Baseline Basic Science Bias Blinding Definition An abstract is a summary of a research article. It usually includes the purpose, methods,
More informationDiscordant MIC Analysis: Tes5ng for Superiority within a Non- inferiority Trial
Discordant MIC Analysis: Tes5ng for Superiority within a Non- inferiority Trial Dean Follmann, Erica BriDain, and John Powers Na5onal Ins5tute of Allergy and Infec5ous Diseases November 19, 2014 1 Current
More informationThe Role of PCP in Prostate Cancer Screening Beaver Creek Ma< T. Rosenberg
The Role of PCP in Prostate Cancer Screening Beaver Creek 2017 Ma< T. Rosenberg A Cri@cal Look at the Historical Flow Pa@ent concern Office visit History DRE PSA Biopsy Specimen with pathologist Too Many
More information95% 2.5% 2.5% +2SD 95% of data will 95% be within of data will 1.96 be within standard deviations 1.96 of sample mean
Efficient Clinical Trials John H. Powers, MD Senior Medical Scientist SAIC in support of Clinical Collaborative Research Branch NIAID/NIH Introduction Definitions what is a small clinical trial? Review
More informationWhat is Data? Part 2: Patterns & Associations. INFO-1301, Quantitative Reasoning 1 University of Colorado Boulder
What is Data? Part 2: Patterns & Associations INFO-1301, Quantitative Reasoning 1 University of Colorado Boulder August 29, 2016 Prof. Michael Paul Prof. William Aspray Overview This lecture will look
More informationManagement of Acute Ischemic Stroke. Learning Objec=ves. What is a Stroke? Jen Simpson Neurohospitalist
Management of Acute Ischemic Stroke Jen Simpson Neurohospitalist Learning Objec=ves Iden=fy signs/symptoms of stroke Recognize pa=ents who may be eligible for treatment of acute stroke What is a Stroke?
More informationDesigning and Analyzing RCTs. David L. Streiner, Ph.D.
Designing and Analyzing RCTs David L. Streiner, Ph.D. Emeritus Professor, Department of Psychiatry & Behavioural Neurosciences, McMaster University Emeritus Professor, Department of Clinical Epidemiology
More informationPropensity Score. Overview:
Propensity Score Overview: What do we use a propensity score for? How do we construct the propensity score? How do we implement propensity score es
More informationCS 5306 INFO 5306: Crowdsourcing and. Human Computation. Lecture 10. 9/26/17 Haym Hirsh
CS 5306 INFO 5306: Crowdsourcing and Human Computation Lecture 10 9/26/17 Haym Hirsh Infotopia, Chapter 3 Four Big Problems for Deliberating Groups Four Big Problems for Deliberating Groups Amplifying
More informationProcess of Science and hypothesis tes2ng in Behavioral Ecology
Process of Science and hypothesis tes2ng in Behavioral Ecology Goal: understand the way that scien2fic hypotheses and methodologies are used to gain knowledge. What separates science from non- science?
More informationWomen s Oral Health An overview. Dr Paula Vassallo President Council of European Chief Dental Officers
Women s Oral Health An overview Dr Paula Vassallo President Council of European Chief Dental Officers Defini@on Women s Health has been defined as diseases or condi@ons that are unique to, more prevalent
More informationIntroduction. Lecture 1. What is Statistics?
Lecture 1 Introduction What is Statistics? Statistics is the science of collecting, organizing and interpreting data. The goal of statistics is to gain information and understanding from data. A statistic
More informationDr. Alessio Signori Longitudinal trajectories of EDSS in primary progressive MS pa:ents A latent class approach
Dr. Alessio Signori Longitudinal trajectories of EDSS in primary progressive MS pa:ents A latent class approach Department of Health Sciences Section of Biostatistics University of Genoa, Italy Mul%ple
More informationPrac%ced based research networks and evidenced based den%stry : A bridge to help close the research to prac%ce gap. Southwest Region Annual Mee8ng
Prac%ced based research networks and evidenced based den%stry : A bridge to help close the research to prac%ce gap. Southwest Region Annual Mee8ng Miami, Fl. Febuary 21, 2014 Paul Benjamin DMD, MAGD, FACD
More informationBiosta's'cs Board Review. Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016
Biosta's'cs Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016 Review key biosta's'cs concepts Understand 2 X 2 tables Objec'ves By the end of this
More informationNeurocogni*ve tes*ng and cochlear implanta*on: insights into performance in older adults
Neurocogni*ve tes*ng and cochlear implanta*on: insights into performance in older adults Maura K Cosetti 1 MD James B. Pinkston, PhD 1 ; Jose M. Flores, MPH, PhD 3 ; David R. Friedmann, MD 2 ; Callie B.
More informationKey Statistical Considerations. Dr Delva Shamley
Key Statistical Considerations Dr Delva Shamley WHAT STATISTICAL INFORMATION DO YOU NEED FOR A RESEARCH PROJECT? 1. Sample Size 2. Details of the type of data you will get from your outcome measures 3.
More informationChapter 1 - Sampling and Experimental Design
Chapter 1 - Sampling and Experimental Design Read sections 1.3-1.5 Sampling (1.3.3 and 1.4.2) Sampling Plans: methods of selecting individuals from a population. We are interested in sampling plans such
More informationStacie Fruth, PT, DHSc, OCS Michael Brickens, PT Tim Ellender, MD Jenny Gojmerac- Owens, NP Julie Welch, MD. Stacie Fruth, PT, DHSc, OCS
Physical Therapists on the Emergency Department Team: PT and MD Perspec8ves Stacie Fruth, PT, DHSc, OCS Michael Brickens, PT Tim Ellender, MD Jenny Gojmerac- Owens, NP Julie Welch, MD Combined Sec,ons
More informationA large database study in the general population in England
Time-dependent markers of comorbidity severity and change are associated with increased risk of mortality in heart failure: A large database study in the general population in England Claire A. Rushton,
More informationSheesh, Problem behavior!
Crea%ng Communica%ve Competence through Func%onal Communica%on Training Jus*n Cooper Ed.D Robert Pennington Ph.D. BCBA- D Sheesh, Problem behavior! Challenging Behavior and Disabili%es Data suggest that
More informationUsing the electronic medical records to identify patients with hypertension in primary care: A validation study using EMRALD.
Using the electronic medical records to identify patients with hypertension in primary care: A validation study using EMRALD. Noah Ivers, Bogdan Pylypenko, Karen Tu Presentation @ CAHSPR: May 10, 2011
More informationOtis W. Brawley, MD, FACP
The Transformation of American Medicine (A Cancer Prospective) Otis W. Brawley, MD, FACP Chief Medical and Scientific Officer American Cancer Society Professor of Hematology, Medical Oncology, Medicine
More informationAMS 5 EXPERIMENTAL DESIGN
AMS 5 EXPERIMENTAL DESIGN Controlled Experiment Suppose a new drug is introduced, how do we gather evidence that it is effective to treat a given disease? The key idea is comparison. A group of patients
More informationA resource for doctors. An opportunity for patients.
A resource for doctors. An opportunity for patients. A way for experts to work together to provide the best treatment for patients around the world. Our understanding of cancer is constantly growing, making
More informationP. 266 #9, 11. p. 289 # 4, 6 11, 14, 17
P. 266 #9, 11 9. Election. a) Answers will vary. A component is one voter voting. An outcome is a vote for our candidate. Using two random digits, 00-99, let 01-55 represent a vote for your candidate,
More informationFibrillazione atriale subclinica e rischio di ictus ischemico
Fibrillazione atriale subclinica e rischio di ictus ischemico Background 25% of all ischemic strokes are cryptogenic, and subclinical atrial fibrilla;on (AF) is suspected to be a possible cause in many
More informationStudy Design STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL STUDY DESIGN
STUDY DESIGN CASE SERIES AND CROSS-SECTIONAL Daniel E. Ford, MD, MPH Vice Dean for Clinical Investigation Johns Hopkins School of Medicine Introduction to Clinical Research July 15, 2014 STUDY DESIGN Provides
More informationTraining + U*lizing Student Staff as Ac*ve Bystanders
Training + U*lizing Student Staff as Ac*ve Bystanders Ka*e Sorokas Kent State University ksorokas@kent.edu Jennifer O Connell Kent State University joconne5@kent.edu Outline Descrip*on of Kent State University
More informationConflicts of interest. Pulmonary rehabilita8on. Objec8ves / Outline. Pulmonary rehabilita8on in COPD. Pulmonary rehabilita8on in COPD
Conflicts of interest UBC I have no conflicts of interest related to this presenta8on Treatment op+ons From a global perspec+ve: Non- pharmaceu+cal treatments Pulmonary Fibrosis Founda8on Summit La Jolla,
More informationGathering. Useful Data. Chapter 3. Copyright 2004 Brooks/Cole, a division of Thomson Learning, Inc.
Gathering Chapter 3 Useful Data Copyright 2004 Brooks/Cole, a division of Thomson Learning, Inc. Principal Idea: The knowledge of how the data were generated is one of the key ingredients for translating
More informationLesson Plan. Class Policies. Designed Experiments. Observational Studies. Weighted Averages
Lesson Plan 1 Class Policies Designed Experiments Observational Studies Weighted Averages 0. Class Policies and General Information Our class website is at www.stat.duke.edu/ banks. My office hours are
More informationDemonstra*ng Respect & Enhancing Trust: Mastering the Informed Consent Process. Informed consent. Objectives. Why obtain consent for research?
Demonstra*ng Respect & Enhancing Trust: Mastering the Informed Consent Process Michael Green, MD, MPH Professor of Pediatrics, Surgery & Clinical and Transla*onal Science Clinical Transla*onal Science
More informationANONYMITY ONLINE // CLASS 16 FALL 2015 / SECTION 02 / HOLLY BUCK
ANONYMITY ONLINE // CLASS 16 FALL 2015 / SECTION 02 / HOLLY BUCK TODAY S CLASS - Ethical Analysis Assignments - Mini-lecture / readings review - Discussion ANONYMITY the inability of others to identify
More informationMaking comparisons. Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups
Making comparisons Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups Data can be interpreted using the following fundamental
More informationJosep M Borras WP7 Health Care University of Barcelona and Spanish Cancer Strategy Brussels, June 23, 2014
THE IMPORTANCE OF SHARING EXPERTISE AND THE CHALLENGE TO MANAGE THE EXCHANGE OF KNOWLEDGE IN HIGHLY SPECIALISED HEALTH CARE: a perspec(ve from the European Partnership Ac(on Against Cancer (EPAAC) Josep
More informationEPSE 594: Meta-Analysis: Quantitative Research Synthesis
EPSE 594: Meta-Analysis: Quantitative Research Synthesis Ed Kroc University of British Columbia ed.kroc@ubc.ca March 28, 2019 Ed Kroc (UBC) EPSE 594 March 28, 2019 1 / 32 Last Time Publication bias Funnel
More informationDescribe the pain and it s location:
WELCOME TO ZIVKOVIC CHIROPRACTIC CENTER DATE: Please print clearly and fill in completely. ABOUT YOU: Patient Name:_ What do you prefer to be called:_ SS# Street Address City State Zip Date of Birth: Age:
More informationUpper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines.
Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines Chris,ne McDonough, PhD, PT, CEEAA Health Outcomes Unit Department of Health
More informationlab exam lab exam Experimental Design Experimental Design when: Nov 27 - Dec 1 format: length = 1 hour each lab section divided in two
lab exam when: Nov 27 - Dec 1 length = 1 hour each lab section divided in two register for the exam in your section so there is a computer reserved for you If you write in the 1st hour, you can t leave
More informationInternational Travel Medical Questionnaire
International Travel Medical Questionnaire Name: of Birth: Gender: M/F Last First Month/Day/Year Circle One Address: Street City, State Zip Daytime Phone: Evening Phone: Primary care physician: Emergency
More informationOffice of Training and Capacity Development AIDS Educa<on and Training Centers Overview
Office of Training and Capacity Development AIDS Educa
More informationData Collection: Validity & Ethics
Data Collection: Validity & Ethics Data Integrity Expectancy effects & their control Experimenter expectancy effects Participant Expectancy Effects Single- and Double-blind designs Researcher and Participant
More informationPlace of surgery in diagnos1c and therapeu1c strategies: New challenges
Place of surgery in diagnos1c and therapeu1c strategies: New challenges Philippe Métellus M.D., Ph.D. Department of Neurosurgery, CHU Timone, Marseille, France Place of surgery in diagnos1c and therapeu1c
More informationTrial Designs. Professor Peter Cameron
Trial Designs Professor Peter Cameron OVERVIEW Review of Observational methods Principles of experimental design applied to observational studies Population Selection Looking for bias Inference Analysis
More informationApplied Analysis of Variance and Experimental Design. Lukas Meier, Seminar für Statistik
Applied Analysis of Variance and Experimental Design Lukas Meier, Seminar für Statistik About Me Studied mathematics at ETH. Worked at the statistical consulting service and did a PhD in statistics (at
More informationHow do we identify a good healthcare provider? - Patient Characteristics - Clinical Expertise - Current best research evidence
BSC206: INTRODUCTION TO RESEARCH METHODOLOGY AND EVIDENCE BASED PRACTICE LECTURE 1: INTRODUCTION TO EVIDENCE- BASED MEDICINE List 5 critical thinking skills. - Reasoning - Evaluating - Problem solving
More informationLocal EBQ Course - PERU Epidemiology, Biostatistics & Qualitative Research Methods
, Biostatistics & 20 places available Iquitos, Peru Apply now for this 3-week course! Applica7on procedure and criteria for academic eligibility and funding can be found on www.uantwerp.be/ebq-peru Deadline
More informationRecrea&onal Therapy. Thomas K. Skalko, Ph.D., LRT/CTRS Chair, Commi<ee on Accredita&on of Recrea&onal Therapy Educa&on
Recrea&onal Therapy Thomas K. Skalko, Ph.D., LRT/CTRS Chair, Commi
More informationClinical Research Project Design and Guidelines: Choosing a Research Ques8on
Clinical Research Project Design and Guidelines: Choosing a Research Ques8on Odunayo M. Oluwatosin, FMCS (Nig) Department of Plas?c Surgery University College Hospital Ibadan 1 Learning outcome: by the
More informationA Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons?
A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons? Michael Hogarth, MD, FACP CMIO, Athena Breast Health Network Professor,
More informationPrevious Example. New. Tradition
Experimental Design Previous Example New Tradition Goal? New Tradition =? Challenges Internal validity How to guarantee what you have observed is true? External validity How to guarantee what you have
More informationMeasuring impact. William Parienté UC Louvain J PAL Europe. povertyactionlab.org
Measuring impact William Parienté UC Louvain J PAL Europe povertyactionlab.org Course overview 1. What is evaluation? 2. Measuring impact 3. Why randomize? 4. How to randomize 5. Sampling and Sample Size
More informationCreative Commons Attribution-NonCommercial-Share Alike License
Author: Brenda Gunderson, Ph.D., 2015 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution- NonCommercial-Share Alike 3.0 Unported License:
More informationBuprenorphine Prescribing as a Patient- Centered Medical Home Enhancement
Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement TANNER NISSLY DO, BOB LEVY MD FASAM, MICHELE MANDRICH MSW, CMPE AS YOU ENTER, PLEASE SET UP TO PARTICIPATE IN OUR POLL EVERYWHERE
More information